2020 American Transplant Congress Archives - Page 190 of 223

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

Saturday, May 30, 2020

3:51pm-4:03pm: HLA Molecular Mismatch is an Independent Correlate of T-Cell Mediated Rejection and Potential Prognostic Biomarker in Renal Transplantation

C. Wiebe¹, D. Pochinco², I. W. Gibson³, J. Ho¹, P. Birk⁴, A. Goldberg⁴, M. Karpinski⁵, J. Shaw⁵, R. N. David⁵, P. W. Nickerson¹

Biomarkers, Immune Assessment and Clinical Outcomes V • Virtual

3:51pm-4:03pm: Imaging OX40+Alloreactive T Cells Provides Early Warning of Organ Transplant Rejection

T. Hirai¹, A. Mayer², T. W. Nobashi², Z. Xiao², T. Udagawa³, K. Seo⁴, F. Simonetta⁵, J. Baker⁵, A. Cheng³, S. S. Gambhir², R. S. Negrin⁵

Biomarker Discovery and Immune Modulation • Virtual

3:51pm-4:03pm: Impact of Donor Multidrug-Resistant Organisms on Risk of Recipient Infection

J. A. Anesi¹, E. A. Blumberg¹, J. H. Han², D. H. Lee³, H. Clauss⁴, R. Hasz⁵, E. Molnar⁴, D. Alimenti¹, A. R. Motzer⁴, S. West⁵, W. B. Bilker¹, P. Tolomeo¹, E. Lautenbach¹, T. Prevention Epicenters Program⁶

Antimicrobial & Diagnostic Stewardship in Transplantation • Virtual

3:51pm-4:03pm: Impact of Eplet Mismatches on the Risk of Graft Loss: Not All Eplets are Created Equal

H. Mohammadhassanzadeh¹, W. Klement², H. Gebel³, B. Foster⁴, P. Keown⁵, K. Oualkacha⁶, R. Sapir-Pichhadze¹

Biomarkers, Immune Assessment and Clinical Outcomes VI • Virtual

3:51pm-4:03pm: Impact of Ozone Exposure of Lung Donors and Recipients on All-Cause Mortality after Lung Transplant

T. Egan¹, S. Arunachalam², C. Chang², P. Strassle¹

From Bench to Community to Bedside in Lung Transplantation • Virtual

3:51pm-4:03pm: Improving Liver Transplant (LT) Waitlist Attrition

W. Concepcion¹, A. Ahmed¹, Z. Tulu², L. Hogan², A. Bonham¹, A. Gallo¹, M. Melcher¹, P. Kwo¹, C. Esquivel¹

Quality Assurance Process Improvement & Regulatory Issues II • Virtual

3:51pm-4:03pm: Incident Malignancies among Post Kidney-Transplant Patients by Type of Induction Immunosuppression and by Age

L. Wang, J. Motter, S. Bae, D. Segev, M. McAdams DeMarco

Kidney Immunosuppression: Induction Therapy • Virtual

3:51pm-4:03pm: Induction Immunosuppression in Primary Pediatric Liver Transplant Recipients

T. Shaker¹, K. Ramanathan¹, S. Riad², D. Vock³, S. Chinnakotla¹

Liver: Pediatrics • Virtual

3:51pm-4:03pm: Interim Experience in a Phase 3 Prospective, Randomized, Multi-Center, Open-Label, Controlled Trial of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-Matched, Living Donor Kidney Transplants

D. Kaufman¹, J. Piper², M. Stegall³, S. Akkina⁴, E. Marin⁵, A. Gaber⁶, Y. Qasi⁷, T. Srinivas⁸, D. Alonso⁹, A. Patel¹⁰, M. Laftavi¹¹, A. Shah¹², S. Collette¹³, E. Stites¹⁴, K. Chavin⁸, S. Crowley¹⁵

Late Breaking Oral Abstract • Virtual

3:51pm-4:03pm: Kidney after Intestinal Transplantation: A Comparison with Combined Kidney with Intestinal Transplant. A UNOS Database Analysis

A. Sharfuddin, M. Panezai, O. Adebiyi, T. Taber, M. Yaqub

Intestinal Transplantation • Virtual